The anti-fibrotic effect of GV1001 combined with gemcitabine on treatment of pancreatic ductal adenocarcinoma

GV1001 is a telomerase-based cancer vaccine made of a 16-mer telomerase reverse transcriptase (TERT) peptide, and human TERT, the rate-limiting subunit of the telomerase complex, is an attractive target for cancer vaccination. The aim of this study was to evaluate the effect of telomerase peptide va...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Joo Kyung, Kim, Yejin, Kim, Hyemin, Jeon, Jane, Kim, Tae Wan, Park, Ji-Hong, Hwnag, Young-il, Lee, Wang Jae, Kang, Jae Seung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342724/
https://www.ncbi.nlm.nih.gov/pubmed/27655706
http://dx.doi.org/10.18632/oncotarget.12057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342724/
https://www.ncbi.nlm.nih.gov/pubmed/27655706
http://dx.doi.org/10.18632/oncotarget.12057

Ejemplares similares